Evidence map›Paper›PMID 30781512›Full record

ArticleInternational journal of molecular sciences2019

Shedding Light on the Interaction of Human Anti-Apoptotic Bcl-2 Protein with Ligands through Biophysical and in Silico Studies.

Joao Ramos, Jayaraman Muthukumaran, Filipe Freire, João Paquete-Ferreira, Ana Rita Otrelo-Cardoso, Dmitri Svergun, Alejandro Panjkovich, Teresa Santos-Silva

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Frontiers in pharmacology · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Computational study on novel natural inhibitors targeting BCL2.Medical oncology (Northwood, London, England) · 2021
    Article
  10. HybridACS pharmacology & translational science · 2021
    Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Joao RamosUCIBIO-NOVA, Departamento de Química, Faculdade de Ciências e Tecnologia, Universidade NOVA de Lisboa, 2829-516 Caparica, Portugal. jc.ramos@campus.fct.unl.pt.
Jayaraman MuthukumaranUCIBIO-NOVA, Departamento de Química, Faculdade de Ciências e Tecnologia, Universidade NOVA de Lisboa, 2829-516 Caparica, Portugal. muthu@fct.unl.pt.
Filipe FreireUCIBIO-NOVA, Departamento de Química, Faculdade de Ciências e Tecnologia, Universidade NOVA de Lisboa, 2829-516 Caparica, Portugal. f.freire@campus.fct.unl.pt.ORCID 0000-0002-5310-0668
João Paquete-FerreiraUCIBIO-NOVA, Departamento de Química, Faculdade de Ciências e Tecnologia, Universidade NOVA de Lisboa, 2829-516 Caparica, Portugal. jcp.ferreira@campus.fct.unl.pt.
Ana Rita Otrelo-CardosoUCIBIO-NOVA, Departamento de Química, Faculdade de Ciências e Tecnologia, Universidade NOVA de Lisboa, 2829-516 Caparica, Portugal. a.cardoso@campus.fct.unl.pt.
Dmitri SvergunEuropean Molecular Biology Laboratory (EMBL), Hamburg Outstation, c/o DESY, 22067 Hamburg, Germany. svergun@embl-hamburg.de.
Alejandro PanjkovichEuropean Molecular Biology Laboratory (EMBL), Hamburg Outstation, c/o DESY, 22067 Hamburg, Germany. alejandro.panjkovich@embl-hamburg.de.
Teresa Santos-SilvaUCIBIO-NOVA, Departamento de Química, Faculdade de Ciências e Tecnologia, Universidade NOVA de Lisboa, 2829-516 Caparica, Portugal. tsss@fct.unl.pt.
Universidade Nova de Lisboa · PTEuropean Molecular Biology Laboratory · DE

Funding

ERDF under the PT2020 Partnership Agreement POCI-01-0145-FEDER-007728Fundação para a Ciência e a Tecnologia UID/Multi/04378/2013; SFRH/BPD/97719/2013
6 · The paper itself

Abstract

Bcl-2 protein is involved in cell apoptosis and is considered an interesting target for anti-cancer therapy. The present study aims to understand the stability and conformational changes of Bcl-2 upon interaction with the inhibitor venetoclax, and to explore other drug-target regions. We combined biophysical and in silico approaches to understand the mechanism of ligand binding to Bcl-2. Thermal shift assay (TSA) and urea electrophoresis showed a significant increase in protein stability upon venetoclax incubation, which is corroborated by molecular docking and molecular dynamics simulations. An 18 °C shift in Bcl-2 melting temperature was observed in the TSA, corresponding to a binding affinity multiple times higher than that of any other reported Bcl-2 inhibitor. This protein-ligand interaction does not implicate alternations in protein conformation, as suggested by SAXS. Additionally, bioinformatics approaches were used to identify deleterious non-synonymous single nucleotide polymorphisms (nsSNPs) of Bcl-2 and their impact on venetoclax binding, suggesting that venetoclax interaction is generally favored against these deleterious nsSNPs. Apart from the BH3 binding groove of Bcl-2, the flexible loop domain (FLD) also plays an important role in regulating the apoptotic process. High-throughput virtual screening (HTVS) identified 5 putative FLD inhibitors from the Zinc database, showing nanomolar affinity toward the FLD of Bcl-2.

Indexed as

Biophysical PhenomenaProtein ConformationApoptosisBinding SitesBridged Bicyclo Compounds, HeterocyclicComputer SimulationHumansLigandsMolecular Docking SimulationMolecular Dynamics SimulationPolymorphism, Single NucleotideProtein BindingProto-Oncogene Proteins c-bcl-2SulfonamidesBCL2 protein, humanBridged Bicyclo Compounds, HeterocyclicLigandsProto-Oncogene Proteins c-bcl-2SulfonamidesvenetoclaxBcl-2BH3 mimeticsbioinformaticsbiophysical methodscell apoptosishigh throughput virtual screeningin silicoprotein-ligand interactionsvenetoclax

Identifiers

PMID30781512
PMCPMC6413030
OpenAlexW2911775629

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.